3-氨基-2,5-二羟基苯甲酸 | 98279-58-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 3-氨基-2,5-二羟基苯甲酸
• 英文名称: 3-amino-2,5-dihydroxy-benzoic acid
• 英文别名: 3-Amino-2,5-dihydroxy-benzoesaeure；6-Amino-hydrochinon-carbonsaeure-(2)；3-Amino-gentisinsaeure；3-Amino-2,5-dihydroxybenzoic acid
• CAS: 98279-58-4
• 化学式: C₇H₇NO₄
• mdl: MFCD09955034
• 分子量: 169.137
• InChiKey: CSUJPDBGUZBXIV-UHFFFAOYSA-N

物化性质

• 熔点：
  260-262 °C (decomp)
• 沸点：
  457.6±45.0 °C(Predicted)
• 密度：
  1.672±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.6
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  104
• 氢给体数：
  4
• 氢受体数：
  5

安全信息

• 海关编码：
  2922509090

反应信息

• 作为反应物：
  描述：

  2-Amino-6-hydroxy-[1,4]-benzoquinone 、 Farnesyl dibenzodiazepinone 、 5-deoxy-5-amino-shikimic acid 、 (2,3-二羟基-4-氧代-丁氧基)膦酸 、 4,5,6-三羟基-2-氧代-7-膦酰氧基庚酸 、 (4R,5S,6R)-4-Amino-5,6-dihydroxy-2-oxo-7-phosphonooxy-heptanoic acid 、 磷烯醇丙酮酸 、 3-氨基-5-羟基苯甲酸 、 3-氨基-2,5-二羟基苯甲酸 、 以yielding 6-amino-benzene-1,2,4-triol的产率得到6-amino-1,2,4-trioxy-benzene
  参考文献：
  名称：

  Polynucleotides for production of farnesyl dibenzodiazepinones

  摘要：

  该发明提供了参与法尼酰二苯并二氮环酮（包括ECO-04601）生物合成的基因及其编码的蛋白质。该发明涉及包含这些基因的表达载体以及转化为这些载体的宿主细胞。该发明进一步涉及使用该发明中的基因和蛋白质生产法尼酰二苯并二氮环酮化合物的方法，例如在转化的宿主细胞中表达生物合成途径基因。

  公开号：

  US20060172395A1
• 作为产物：
  描述：

  2,5-二羟基-3-硝基-苯甲酸 在 盐酸 、 tin(ll) chloride 作用下， 生成 3-氨基-2,5-二羟基苯甲酸
  参考文献：
  名称：

  Copper interconnects for semiconductor devices

  摘要：

  铜/低介电常数材料正在迅速取代当前半导体器件中传统的铝合金/SiO2基互连。本文回顾了转向铜/低介电常数互连的优势。讨论了在制造铜/低介电常数互连器件过程中面临的材料和工艺挑战。突出了与此类器件相关的可靠性问题。

  DOI：

  10.1007/s11837-001-0103-y

文献信息

• Farnesyl dibenzodiazepinone, processes for its production and its use as a pharmaceutical
  申请人：Bachmann O. Brian

  公开号：US20050043297A1

  公开（公告）日：2005-02-24

  This invention relates to a novel farnesylated dibenzodiazepinone, named ECO-04601, its pharmaceutically acceptable salts and derivatives, and to methods for obtaining such compounds. One method of obtaining the ECO-04601 compound is by cultivation of a novel strain of Micromonospora sp., 046-ECO11; another method involves expression of biosynthetic pathway genes in transformed host cells. The present invention further relates to Micromonospora sp. strain 046-ECO11, to the use of ECO-04601 and its pharmaceutically acceptable salts and derivatives as pharmaceuticals, in particular to their use as inhibitors of cancer cell growth, bacterial cell growth, mammalian lipoxygenase, and to pharmaceutical compositions comprising ECO-04601 or a pharmaceutically acceptable salt or derivative thereof. Finally, the invention relates to novel polynucleotide sequences and their encoded proteins, which are involved in the biosynthesis of ECO-04601.

  本发明涉及一种新型的法尼酰化二苯并二氮杂环酮，命名为ECO-04601，其药学上可接受的盐和衍生物，以及获得这种化合物的方法。获得ECO-04601化合物的一种方法是通过培养一种新的微单孢菌株，046-ECO11；另一种方法涉及在转化的宿主细胞中表达生物合成途径基因。本发明还涉及微单孢菌株046-ECO11的使用，以及ECO-04601及其药学上可接受的盐和衍生物作为药物的使用，特别是作为癌细胞生长抑制剂、细菌细胞生长抑制剂、哺乳动物脂肪氧合酶抑制剂，以及包含ECO-04601或其药学上可接受的盐或衍生物的药物组合物。最后，本发明涉及新的多核苷酸序列及其编码的蛋白质，这些蛋白质参与ECO-04601的生物合成。
• Farnesyl dibenzodiazepinone and processes for its production
  申请人：McAlpine James B.

  公开号：US20080199940A1

  公开（公告）日：2008-08-21

  This invention relates to a novel farnesylated dibenzodiazepinone, named ECO-04601, its pharmaceutically acceptable salts and derivatives, and to methods for obtaining such compounds. One method of obtaining the ECO-04601 compound is by cultivation of a novel strain of Micromonospora sp., 046-ECO11; another method involves expression of biosynthetic pathway genes in transformed host cells. The present invention further relates to Micromonospora sp. strain 046-ECO11, to the use of ECO-04601 and its pharmaceutically acceptable salts and derivatives as pharmaceuticals, in particular to their use as inhibitors of cancer cell growth, bacterial cell growth, mammalian lipoxygenase, and to pharmaceutical compositions comprising ECO-04601 or a pharmaceutically acceptable salt or derivative thereof. Finally, the invention relates to novel polynucleotide sequences and their encoded proteins, which are involved in the biosynthesis of ECO-04601.

  本发明涉及一种新型的法尼醇基二苯并二氮杂环酮，命名为ECO-04601，其药物可接受的盐和衍生物，以及获得这种化合物的方法。获得ECO-04601化合物的一种方法是通过培养一种新的微单孢菌株Micromonosporasp. 046-ECO11; 另一种方法涉及在转化的宿主细胞中表达生物合成途径基因。本发明还涉及Micromonosporasp.株046-ECO11的使用，以及ECO-04601及其药物可接受的盐和衍生物作为药物的使用，特别是作为癌细胞生长抑制剂，细菌细胞生长抑制剂，哺乳动物脂氧合酶以及包含ECO-04601或其药物可接受的盐或衍生物的药物组合物。最后，本发明涉及新的多核苷酸序列及其编码的蛋白质，这些蛋白质参与ECO-04601的生物合成。
• FARNESYL DIBENZODIAZEPINONE AND PROCESSES FOR ITS PRODUCTION
  申请人：ZAZOPOULOS Emmanuel

  公开号：US20090263886A1

  公开（公告）日：2009-10-22

  This invention relates to a novel farnesylated dibenzodiazepinone, named ECO-04601, its pharmaceutically acceptable salts and derivatives, and to methods for obtaining such compounds. One method of obtaining the ECO-04601 compound is by cultivation of a novel strain of Micromonospora sp., 046-ECO11; another method involves expression of biosynthetic pathway genes in transformed host cells. The present invention further relates to Micromonospora sp. strain 046-ECO11, to the use of and its pharmaceutically acceptable salts and derivatives as pharmaceuticals, in particular to their use as inhibitors of cancer cell growth, bacterial cell growth, mammalian lipoxygenase, and to pharmaceutical compositions comprising ECO-04601 or a pharmaceutically acceptable salt or derivative thereof. Finally, the invention relates to novel polynucleotide sequences and their encoded proteins, which are involved in the biosynthesis of ECO-04601.

  本发明涉及一种新型的法尼酰化二苯并二氮平酮，名为ECO-04601，其药学上可接受的盐和衍生物，以及获得这种化合物的方法。获得ECO-04601化合物的一种方法是通过培养一种新的微单孢菌株Micromonosporasp.，046-ECO11；另一种方法涉及在转化的宿主细胞中表达生物合成途径基因。本发明还涉及Micromonosporasp.株系046-ECO11的使用及其药学上可接受的盐和衍生物作为药物，特别是它们作为抑制癌细胞生长、细菌细胞生长、哺乳动物脂氧合酶的药物的使用，以及包含ECO-04601或其药学上可接受的盐或衍生物的药物组合物。最后，本发明涉及新的多核苷酸序列及其编码的蛋白质，这些蛋白质参与ECO-04601的生物合成。
• POLYNUCLEOTIDES FOR PRODUCTION OF FARNESYL DIBENZODIAZEPINONES
  申请人：Farnet Chris M.

  公开号：US20080131943A1

  公开（公告）日：2008-06-05

  This invention provides genes and their encoded proteins, involved in the biosynthesis of farnesyl dibenzodiazepinones, including ECO-04601. The invention relates to expression vectors comprising the genes and to host cells transformed with these vectors. The invention further relates to methods of producing farnesyl dibenzodiazepinone compounds using the genes and proteins of the invention, for example, involving expression of biosynthetic pathway genes in transformed host cells.

  本发明提供了参与芳基二苯并二氮环酮的生物合成的基因及其编码的蛋白质，包括ECO-04601。本发明涉及包含这些基因的表达载体以及转化为这些载体的宿主细胞。本发明还涉及使用本发明的基因和蛋白质生产芳基二苯并二氮环酮化合物的方法，例如，在转化的宿主细胞中表达生物合成途径基因。
• Farnesyl dibenzodiazepinone, and processes for its production
  申请人：Ecopia BioSciences, Inc.

  公开号：US07101872B2

  公开（公告）日：2006-09-05

  This invention relates to a novel farnesylated dibenzodiazepinone, named ECO-04601, its pharmaceutically acceptable salts and derivatives, and to methods for obtaining such compounds. One method of obtaining the ECO-04601 compound is by cultivation of a novel strain of Micromonospora sp., 046-ECO11; another method involves expression of biosynthetic pathway genes in transformed host cells. The present invention further relates to Micromonospora sp. strain 046-ECO11, to the use of ECO-04601 and its pharmaceutically acceptable salts and derivatives as pharmaceuticals, in particular to their use as inhibitors of cancer cell growth, bacterial cell growth, mammalian lipoxygenase, and to pharmaceutical compositions comprising ECO-04601 or a pharmaceutically acceptable salt or derivative thereof. Finally, the invention relates to novel polynucleotide sequences and their encoded proteins, which are involved in the biosynthesis of ECO-04601.

  本发明涉及一种新型的法尼酰化二苯并二氮杂环酮，命名为ECO-04601，其药学上可接受的盐和衍生物，以及获得这种化合物的方法。获得ECO-04601化合物的一种方法是通过培养一种新的Micromonospora sp. 046-ECO11菌株；另一种方法涉及在转化的宿主细胞中表达生物合成途径基因。本发明还涉及Micromonospora sp. 046-ECO11菌株的使用，使用ECO-04601及其药学上可接受的盐和衍生物作为药物，特别是作为癌细胞生长抑制剂、细菌细胞生长抑制剂、哺乳动物脂氧合酶抑制剂，并且涉及包含ECO-04601或其药学上可接受的盐或衍生物的药物组合物。最后，本发明涉及新颖的多核苷酸序列及其编码的蛋白质，这些蛋白质参与ECO-04601的生物合成。